Skip to main content
. 2021 Apr 1;203(7):893–905. doi: 10.1164/rccm.202008-3266OC

Table 1.

Summary of Asthma Prevalence Data by Measures of COVID-19 Severity

  Hospital Admission*
COVID-19 Severity
COVID-19 Survival
Hospitalized Not Hospitalized Severe Not Severe Died Survived
Asthma prevalence, % 10.0 (8.0–12.2) 9.5 (8.0–11.0) 9.9 (7.8–12.3) 8.2 (7.0–10.0) 7.1 (5.6–8.8) 8.6 (7.0–10.3)
Pooled prevalence ratio 1.06 (0.94–1.19); P = 0.37 1.18 (0.98–1.42); P = 0.07 0.89 (0.77–1.02); P = 0.09

Definition of abbreviation: COVID-19 = coronavirus disease.

Numbers in the parentheses are 95% confidence intervals.

*

Hospitalization: 26 studies, n = 385,737.

Severity (among patients who survived during the study period): 42 studies, n = 180,770.

Mortality: 43 studies, n = 311,732.